NewsEvents

Your Yourlocation: Home > Treatment of 26 cases of moderate to severe bronchial asthma with chronic obstructive pulmonary disease by tiotropium bromide(136310-93-5) combined with low-dose budesonide dermoterol

To observe the effect of domestic tiotropium bromide(136310-93-5) combined with budesonide dermoterol on moderate to severe bronchial asthma and chronic obstructive pulmonary disease (COPD).

Methods: Fifty-one patients were divided into treatment group(n = 26) and control group (n = 25) by randomized, double-blind method. The treatment group was treated with tiotropium bromide(136310-93-5) combined with low-dose budesenide dermotam, A moderate dose of budesonide dermotam was given for 12 months.

Results: Compared with the control group, the quality of life scores and the number of acute attack were statistically significant(P <0.05).

Conclusion: Domestic tiotropium bromide(136310-93-5) combined with low-dose budesonide dermotam inhalation in the treatment of moderate to severe bronchial asthma with chronic obstructive pulmonary disease, compared with the use of moderate doses of budesonide dermacentate, in improving the quality of life of patients , To reduce the number of acute exacerbations more advantages.

Address: TEL:0531-82375879 Tiotropium Bromide
© Copyright(C)2014 JINAN DEXINJIA BIO & TECH CO., LTD All Rights Reserved